201. Bevacizumab Promotes T-Cell-Mediated Collagen Deposition in the Mouse Model of Conjunctival Scarring.
- Author
-
Seet LF, Toh LZ, Chu S, Finger SN, Ginhoux F, Hong W, and Wong TT
- Subjects
- Animals, Collagen Type I metabolism, Collagen Type I, alpha 1 Chain, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Eye Injuries drug therapy, Fibroblasts metabolism, Immunohistochemistry, Mice, Vascular Endothelial Growth Factor A metabolism, Angiogenesis Inhibitors pharmacology, Bevacizumab pharmacology, Collagen metabolism, Conjunctiva injuries, Conjunctiva metabolism, Conjunctival Diseases drug therapy, T-Lymphocytes cytology, T-Lymphocytes metabolism
- Abstract
Purpose: We determine the effects of bevacizumab on collagen production in a mouse model of conjunctival scarring., Methods: Experimental surgery was performed as described for the mouse model of conjunctival scarring, and bevacizumab was introduced by conjunctival injection. The capacity of bevacizumab to recognize conjunctival VEGF-A was determined by ELISA. Col1a1 was measured by real-time PCR and immunoblotting. T cells and collagen were visualized by immunofluorescence and picrosirius red staining of bleb cryosections. Conjunctival CD4+ or CD8a+ T cells were counted by flow cytometry. Mouse splenic T cells were cultured with bevacizumab/IgG and their numbers, cell cycle, and collagen production were measured using a cell counter, flow cytometry, and sircol soluble collagen assay, respectively. Reconstitution experiments in severe combined immunodeficiency (SCID) mice were performed by injection of freshly isolated T cells on day 2 postoperatively., Results: Bevacizumab recognized approximately 20% of endogenous murine VEGF-A. Injection of bevacizumab raised Col1a1 expression in the blebs at mRNA and protein levels. Bevacizumab did not induce collagen in conjunctival fibroblasts, but increased CD4+ and CD8a+ cell numbers as well as collagen production by these cells. Collagen appeared to accumulate in the vicinity of T cells in the bevacizumab-treated blebs. While SCID blebs did not show elevated collagen levels, reconstitution with CD4+ or CD8a+ cells resulted in increased Col1a1 expression at mRNA and protein levels., Conclusions: Bevacizumab increased collagen production in the mouse model of conjunctival scarring. This collagen induction was mediated by T cells that were also stimulated by bevacizumab to increase in numbers.
- Published
- 2018
- Full Text
- View/download PDF